Stefania Paolucci Selected Research

Stefania Paolucci Research Topics

Disease

17	Infections 03/2024 - 04/2002
5	Fibrosis (Cirrhosis) 10/2021 - 01/2018
4	COVID-19 04/2022 - 03/2021
3	Chronic Hepatitis C 10/2021 - 01/2019
2	Hepatitis C 12/2019 - 10/2012
2	Virus Diseases (Viral Diseases) 10/2012 - 01/2011
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2011 - 06/2008
2	HIV Infections (HIV Infection) 06/2008 - 02/2004
1	Viremia 07/2023
1	Breakthrough Infections 10/2021
1	Inflammation (Inflammations) 10/2021
1	Common Variable Immunodeficiency 09/2021
1	Portal Hypertension 09/2021
1	Hepatopulmonary Syndrome 09/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Coinfection 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Hypersensitivity (Allergy) 05/2016
1	Colitis 02/2015
1	Neoplasms (Cancer) 01/2014
1	Hemolytic Anemia 09/2012
1	Influenza in Birds (Avian Flu) 01/2011
1	Communicable Diseases (Infectious Diseases) 06/2008
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2005
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 02/2004
1	Substance-Related Disorders (Drug Abuse) 03/2003
1	Retinitis 04/2002

Drug/Important Bio-Agent (IBA)

9	Antiviral Agents (Antivirals)IBA 03/2024 - 12/2013
6	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2011
4	Ribavirin (Virazole)FDA LinkGeneric 01/2021 - 09/2012
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2011
3	RNA (Ribonucleic Acid)IBA 12/2019 - 01/2011
3	Peptide Hydrolases (Proteases)FDA Link 06/2008 - 03/2003
2	velpatasvirIBA 03/2024 - 01/2021
2	voxilaprevirIBA 03/2024 - 01/2021
2	SofosbuvirIBA 03/2024 - 01/2021
2	BNT162 VaccineIBA 04/2022 - 10/2021
2	Ganciclovir (Cytovene)FDA LinkGeneric 09/2021 - 02/2015
2	Viral DNAIBA 03/2021 - 01/2014
2	glecaprevir and pibrentasvirIBA 01/2021 - 01/2019
2	InterferonsIBA 01/2020 - 11/2015
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2012 - 03/2003
1	Neutralizing AntibodiesIBA 04/2022
1	VaccinesIBA 10/2021
1	COVID-19 VaccinesIBA 10/2021
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 10/2021
1	TransferasesIBA 10/2021
1	letermovirIBA 09/2021
1	Valganciclovir FDA Link 09/2021
1	Immunoglobulin G (IgG)IBA 08/2021
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 12/2019
1	ombitasvirIBA 01/2018
1	paritaprevirIBA 01/2018
1	Ritonavir (Norvir)FDA Link 01/2018
1	abacavir (Ziagen)FDA Link 05/2016
1	HLA-B57 antigenIBA 05/2016
1	SteroidsIBA 02/2015
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2013
1	Glycoproteins (Glycoprotein)IBA 12/2013
1	Inosine TriphosphataseIBA 09/2012
1	LigandsIBA 01/2011
1	src-Family KinasesIBA 01/2011
1	AntigensIBA 05/2009
1	Monoclonal AntibodiesIBA 02/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2004
1	Stavudine (Zerit)FDA LinkGeneric 02/2004
1	Didanosine (Videx)FDA LinkGeneric 02/2004
1	Indinavir (Crixivan)FDA Link 02/2004
1	Hydroxyurea (Hydrea)FDA LinkGeneric 02/2004
1	Human immunodeficiency virus 1 p16 proteaseIBA 03/2003
1	Complex MixturesIBA 04/2002

Therapy/Procedure

5	Therapeutics 07/2023 - 02/2004
2	Highly Active Antiretroviral Therapy (HAART) 02/2004 - 04/2002
1	Liver Transplantation 09/2021
1	Retreatment 01/2021
1	Duration of Therapy 01/2019